Martin Meglasson

2014 - Bellerophon Therapeutics

In 2014, Martin Meglasson earned a total compensation of $652.6K as former Chief Scientific Officer at Bellerophon Therapeutics.

Compensation breakdown

Bonus$266,160
Option Awards$79,246
Salary$307,154
Total$652,560

Meglasson received $307.2K in salary, accounting for 47% of the total pay in 2014.

Meglasson also received $266.2K in bonus and $79.2K in option awards.

Rankings

In 2014, Martin Meglasson's compensation ranked 9,341st out of 13,032 executives tracked by ExecPay. In other words, Meglasson earned more than 28.3% of executives.

ClassificationRankingPercentile
All
9,341
out of 13,032
28th
Division
Manufacturing
3,511
out of 4,966
29th
Major group
Chemicals And Allied Products
1,190
out of 1,686
29th
Industry group
Drugs
942
out of 1,365
31st
Industry
Pharmaceutical Preparations
720
out of 1,043
31st
Source: SEC filing on April 27, 2016.

Meglasson's colleagues

We found two more compensation records of executives who worked with Martin Meglasson at Bellerophon Therapeutics in 2014.

2014

Jonathan Peacock

Bellerophon Therapeutics

Chief Executive Officer

2014

Reinilde Heyrman

Bellerophon Therapeutics

former Chief Clinical Development Officer

You may also like